X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
index medicus (16) 16
male (11) 11
abridged index medicus (10) 10
female (10) 10
middle aged (10) 10
cardiovascular (9) 9
anticoagulants (8) 8
mortality (8) 8
stroke (8) 8
drug therapy (7) 7
internal medicine (7) 7
risk factors (7) 7
atrial fibrillation (6) 6
cardiac & cardiovascular systems (6) 6
cardiovascular disease (5) 5
care and treatment (5) 5
endocrinology & metabolism (5) 5
management (5) 5
warfarin (5) 5
aged (4) 4
aspirin (4) 4
atrial fibrillation - drug therapy (4) 4
cardiac arrhythmia (4) 4
comorbidity (4) 4
dabigatran (4) 4
diabetes (4) 4
diagnosis (4) 4
emergency (4) 4
health aspects (4) 4
hemorrhage - chemically induced (4) 4
placebos (4) 4
prevalence (4) 4
prevention (4) 4
prognosis (4) 4
pulmonary embolism (4) 4
research (4) 4
statins (4) 4
type 2 diabetes (4) 4
analysis (3) 3
body mass index (3) 3
cardiovascular diseases (3) 3
cohort studies (3) 3
complications and side effects (3) 3
coronary-artery-disease (3) 3
diabetes mellitus, type 2 - physiopathology (3) 3
double-blind method (3) 3
fibrinolytic agents - therapeutic use (3) 3
heart attacks (3) 3
medicine, general & internal (3) 3
multivariate analysis (3) 3
oral anticoagulants (3) 3
practice guidelines as topic (3) 3
pulmonary embolism - blood (3) 3
pulmonary embolism - diagnosis (3) 3
pulmonary/respiratory (3) 3
registries (3) 3
retrospective studies (3) 3
stroke - prevention & control (3) 3
studies (3) 3
time factors (3) 3
treatment outcome (3) 3
acute kidney injury - chemically induced (2) 2
aged, 80 and over (2) 2
andexanet alpha (2) 2
angiography (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
anticoagulants - adverse effects (2) 2
anticoagulants - therapeutic use (2) 2
antidote (2) 2
antithrombins - adverse effects (2) 2
antithrombotic treatment (2) 2
arginine - analogs & derivatives (2) 2
arginine - therapeutic use (2) 2
atrial fibrillation - complications (2) 2
beta-alanine - analogs & derivatives (2) 2
biomarkers - blood (2) 2
blood platelets (2) 2
brachial-artery (2) 2
cancer (2) 2
clinical protocols (2) 2
congenital heart disease (2) 2
contrast media - adverse effects (2) 2
coronary angiography - adverse effects (2) 2
coronary artery disease - diagnostic imaging (2) 2
coronary vessels (2) 2
critical care medicine (2) 2
d-dimer (2) 2
dabigatran - adverse effects (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
drug dosages (2) 2
drug resistance (2) 2
emergency medicine (2) 2
endothelium (2) 2
endothelium, vascular - physiopathology (2) 2
euro heart survey (2) 2
factor xa - therapeutic use (2) 2
factor xa inhibitors - adverse effects (2) 2
fda approval (2) 2
follow-up studies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 14, pp. 1395 - 1397
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2010, Volume 123, Issue 7, pp. e13 - e13
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2442 - 2444
  [...]our results indicate that the 75-mg b.i.d. dabigatran regimen does not result in drug accumulation beyond 5 days of treatment. [...]our study findings... 
Cardiovascular | Internal Medicine | Chronic kidney failure | Care and treatment | Plasma | Aspirin | FDA approval | Kidney diseases | Drug dosages | Patients
Journal Article
Journal Article
American Journal of Emergency Medicine, ISSN 0735-6757, 2016, Volume 34, Issue 11, pp. 46 - 51
Abstract As expected with all antithrombotic agents, there is a risk of bleeding complications in patients receiving direct oral anticoagulants (DOACs) because... 
Emergency | ANTIDOTE | ANDEXANET ALPHA | DABIGATRAN | MANAGEMENT | EFFICACY | PHARMACOKINETICS | EMERGENCY MEDICINE | WARFARIN | SAFETY | ORAL ANTICOAGULANTS | TOLERABILITY | Piperazines - administration & dosage | Recombinant Proteins - therapeutic use | Factor Xa - administration & dosage | Dabigatran - adverse effects | Humans | Clinical Protocols | Hemorrhage - prevention & control | Thiazoles - antagonists & inhibitors | Recombinant Proteins - adverse effects | Arginine - analogs & derivatives | Thiazoles - adverse effects | Arginine - administration & dosage | Patient Selection | Pyridines - antagonists & inhibitors | Pyridines - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Rivaroxaban - adverse effects | Emergency Treatment | Factor Xa - therapeutic use | Factor Xa - adverse effects | Pyrazoles - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Surgical Procedures, Operative | Piperazines - therapeutic use | Pyridones - antagonists & inhibitors | Dabigatran - antagonists & inhibitors | Anticoagulants - adverse effects | Piperazines - adverse effects | Recombinant Proteins - administration & dosage | Hospitals | Factor Xa Inhibitors - adverse effects | Arginine - adverse effects | Rivaroxaban - antagonists & inhibitors | Hemorrhage - chemically induced | Arginine - therapeutic use | Pyrazoles - antagonists & inhibitors | Pyridones - adverse effects | Practice Guidelines as Topic | Periodical publishing | Anticoagulants (Medicine) | Prothrombin | Thrombin | Comorbidity | Anticoagulants | FDA approval | Laboratories | Hemorrhage
Journal Article
Chest, ISSN 0012-3692, 2016, Volume 149, Issue 5, pp. 1245 - 1251
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 7, pp. 777 - 785
Abstract Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global... 
Cardiovascular | Internal Medicine | registry | oral anticoagulation | atrial fibrillation | Stroke (Disease) | Heart | Anticoagulants (Medicine) | Heart beat | Atrial fibrillation
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 166, Issue 5, pp. e43 - e43
  [...]injected contrast volumes and iodine doses used for the intra-arterial and intravenous contrast procedures could only be assessed in 59% (101/170) of... 
Cardiovascular | Coronary Artery Disease - diagnostic imaging | Acute Kidney Injury - chemically induced | Coronary Angiography - adverse effects | Contrast Media - adverse effects | Humans | Editors
Journal Article
Chest, ISSN 0012-3692, 2011, Volume 140, Issue 4, pp. 1008 - 1015
Background Right ventricular (RV) function is predictive of outcome in patients with acute pulmonary embolism (PE). We assessed the possible incremental value... 
Pulmonary/Respiratory
Journal Article